The FDA says don’t buy young plasma therapies. Here’s why
The U.S. agency warns consumers against the expensive and, so far, unproven therapy
Scientists still haven’t found the fountain of youth. And you shouldn’t pay thousands of dollars to anyone who promises otherwise.
That’s the message from the U.S. Food and Drug Administration, which warned consumers on February 19 against buying infusions of young plasma to counter aging, dementia, Alzheimer’s disease and a variety of other ailments.
“Simply put, we’re concerned that some patients are being preyed upon by unscrupulous actors touting treatments of plasma from young donors as cures and remedies. Such treatments have no proven clinical benefits” and could even cause harm, the FDA statement reads.